SEC Form 4 · accession 0001127602-16-048845
INSULET CORP · PODD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shacey Petrovic
Officer — President, Diabetes Products
Period of report
Apr 1, 2016
Accepted (ET)
Apr 5, 2016 · 4:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001145197
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Apr 1, 2016 | F | 740 | $33.52 | D | 78,782 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations.
- F2Includes 37,977 restricted stock units granted on February 9, 2015, which vest one-half of the total units on February 9, 2017 and one-half of the total units on February 9, 2018; 4,542 performance share units granted on April 1, 2015, which vest one-half of the total performance share units on April 1, 2017 and one-half of the total performance share units on April 1, 2018; and 21,360 restricted stock units granted on February 24, 2016, which vest one-third of the total units on February 24, 2017, one-third of the total units on February 24, 2018 and one-third of the total units on February 24, 2019, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
- F3Includes 712 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on December 31, 2015.